- Lobbying
- Derrick AND White
Lobbying Arrangements Results for 'Derrick White'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Medicare, Medicaid, PDUFA and Patent Reform |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Mr. Derrick White | |||
Details Clean air act regional haze regulations |
WEST Associates
|
Mr. Derrick Forrister | |||
Details issues impacting zoos |
The Columbus Zoological Park Association
|
Shumaker Advisors, LLC | |||
Details Issues related to the opioid crisis. |
Virpax Pharmaceuticals
|
Forbes-Tate | |||
Details Vehicle Safety Act; NHTSA's jurisdiction over "non-operational safety" |
Altec, Inc.
|
Wexler | Walker, a unit of Hill+Knowlton Strategies, LLC | |||
Details Issues related to Biologics. |
AEON Biopharma
|
Forbes-Tate | |||
Details Issues related to monoclonal antibody discovery, research and development. |
Genovac, LLC
|
Forbes-Tate | |||
Details Issues related to market access and COVID-19. |
Kahala Biosciences
|
Forbes-Tate | |||
Details Issues related to the advancement of research and development. |
Syndax Pharmaceuticals
|
Forbes-Tate | |||
Details Issues related to Medicare. |
Contessa Health, Inc.
|
Forbes-Tate | |||
Details Issues related to infectious disease diagnosis. Issues related to infectious disease diagnosis and value-based care. |
Cytovale, Inc.
|
Forbes-Tate | |||
Details Issues related to the federal governments response to COVID-19; Issues related to advanced research and development for COVID-19 response. Issues related to H.R. 925 - The Heroes Act. |
EUSA Pharma LLC
|
Forbes-Tate | |||
Details Issues related to the opioid crisis; Issues related to NIH funding; Issues related to wound care. |
MilanaPharm
|
Forbes-Tate | |||
Details Issues related to senior living and COVID response; Issues related to intergenerational daycare. Issues related to intergenerational daycare. |
Argentum
|
Forbes-Tate | |||
Details Issues related to commercial solutions for an overactive bladder condition. Issues related to H.R. 925 - The Heroes Act. |
Urovant Sciences
|
Forbes-Tate | |||
Details Issues related to agriculture. Issues related to government issues. Issues related to healthcare. Issues related to science and technology. |
Evolva Inc.
|
Forbes-Tate | |||
Details Issues related to COVID-19 response. |
Primmune Therapeutics
|
Forbes-Tate | |||
Details Issues related to kidney health and Medicare Advantage. |
Healthy.io (US), Inc.
|
Forbes-Tate | |||
Details Issues related to home ventilation policies. Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2). |
VieMed Healthcare, Inc.
|
Forbes-Tate | |||
Details Issues related to FDA approval and NIH funding issues. |
Sorrento Therapeutics, Inc.
|
Forbes-Tate | |||
Details Issues related to biopharmaceutical research, development and commercialization. |
Spero Therapeutics, Inc.
|
Forbes-Tate | |||
Details Issues related to biopharmaceutical policy. |
Venatorx Pharmaceuticals
|
Forbes-Tate | |||
Details Issues related to improving patient access for advanced ophthalmic products. |
Eyepoint Pharmaceuticals, Inc.
|
Forbes-Tate | |||
Details Electric vehicle related legislation. |
Bombardier Recreational Products
|
Forbes-Tate | |||
Details Issues related to the development of critical need antimicrobial biopharmaceuticals. |
Antimicrobial Innovation Alliance
|
Forbes-Tate | |||
Details Issues related to biopharmaceutical research and innovation. |
Revangenix
|
Forbes-Tate | |||
Details Issues related to NIDA grants for the research and development of medical technology. Issues related to H.R. 925 - The Heroes Act. |
Abyrx, Inc.
|
Forbes-Tate | |||
Details Issues related to Medicaid enrollment broker issues. |
Conduent Business Services, LLC
|
Forbes-Tate | |||
Details Issues related to primary and specialty care providers and telemedicine. |
Homeward Health
|
Forbes-Tate | |||
Details Issues related to CMS coverage decisions and issues related to healthcare reform. |
Strathspey Crown Holdings, LLC
|
Forbes-Tate | |||
Details Issues related to healthcare, including improving patient access to advanced immunology therapies; Issues related to policies affecting biopharma products pricing, coverage and access in Medicare a... |
Gilead Sciences, Inc.
|
Forbes-Tate | |||
Details Issues regarding access to and reimbursement of proton therapy, including through Medicare and Medicare Advantage. Issues regarding access to proton therapy; Issues regarding the Radiation Oncology... |
National Association of Proton Therapy
|
Forbes-Tate | |||
Details Issues related to CARA implementation; Issues related to opioid abuse; Issues related to FDA; Issues related to FY 2018 Appropriations implementation; Issues related FY 2019 LHHS Appropriations (H... |
Adapt Pharma Inc.
|
Forbes-Tate | |||
Details Issues related to drug pricing; Issues related to 340b; Issues related to trade; Issues related to tax; Issues Related to H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169). |
Bayer Corporation
|
Forbes-Tate | |||
Details Issues related to cosmetics. |
Evolus Beauty
|
Forbes-Tate | |||
Details Issues related to Appropriations, COVID Relief Funds, HRSA. |
Storer Test Express DBA BusTest Express
|
Forbes-Tate | |||
Details Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC). Issues related to Medicare and Medicaid payments... |
American College of Radiology Association
|
Forbes-Tate | |||
Details Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to FDA certi... |
Walgreens Co.
|
Forbes-Tate | |||
Details Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry. |
Verde Technologies
|
Forbes-Tate | |||
Details General issues and regulations impacting the accounting profession. Issues related to VA health care. |
Deloitte LLP
|
Forbes-Tate | |||
Details Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169). |
Halozyme Therapeutics, Inc.
|
Forbes-Tate | |||
Details Issues related to regulations that would restrict operations of farm bureau health insurance plans. |
Tennessee Rural Health Improvement Association
|
Forbes-Tate | |||
Details Issues related to Medicaid and COVID-19. |
Molina Healthcare, Inc.
|
Forbes-Tate | |||
Details Issues related to higher education. |
Jacksonville State University
Higher Educational Institution |
Forbes-Tate | |||
Details Issues related to Medicare and Medicaid reimbursement; Issues related to rare diseases. Issues related to Medicare and Medicaid reimbursement; Issues related to rare diseases; Issues related to new... |
Sarepta Therapeutics
|
Forbes-Tate | |||
Details Issues related to pharmaceutical drugs; Issues related to drug pricing; Issues related to drug pricing in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Medicare Part D; Issues... |
Horizon Therapeutics
|
Forbes-Tate | |||
Details Issues related to implementation of the Infrastructure Investment and Jobs Act (PL 117-58). Issues related to immigration reform. Issues related to FY 2024 Energy and Water Development appropriatio... |
Bipartisan Policy Center Action
|
Forbes-Tate | |||
Details Healthcare legislative issues, including Medicare, Medicaid and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, post acute care reform. Healthcare legislati... |
Northport Health Services
|
Forbes-Tate | |||
Details Issues related to legislation to provide relief during the COVID-19 pandemic; Issues related to advanced research and development for COVID-19 response. Issues related to H.R. 925 - The Heroes Act. |
Bellerophon Therapeutics
|
Forbes-Tate | |||
Details Issues related to Operation WARP Speed, FDA, vaccine development and distribution. Issues related to Operation WARP Speed. |
Arcturus Therapeutics
|
Forbes-Tate |